Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
Titel:
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
Auteur:
Gelderblom, H. Blay, J.Y. Seddon, B.M. Leahy, M. Ray-Coquard, I. Sleijfer, S. Kerst, J.M. Rutkowski, P. Bauer, S. Ouali, M. Marreaud, S. van der Straaten, R.J.H.M. Guchelaar, H.-J. Weitman, S.D. Hogendoorn, P.C.W. Hohenberger, P.